Search Results for: TUBA1A

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases Activate Formins
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • AURKA Activation by TPX2
  • EML4 and NUDC in mitotic spindle formation
  • Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
Novel PGK1 phosphoglycerate kinase 1
  • Glycolysis
  • Gluconeogenesis
  • Manipulation of host energy metabolism
  • Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
  • 3-phospho-D-glyceric acid
  • Copper
  • Artenimol
  • Anemia due to disorders of glycolytic enzymes, including: Hexokinase (HK) deficiency; Phosphoglycerate kinase 1 (PGK1) deficiency; Triose-phosphate isomerase (TPI) deficiency; Glucose phosphate isomerase (GPI) deficiency; Bisphosphoglycerate mutase (BPGM) deficiency
Novel PLA2G7 phospholipase A2 group VII
  • Synthesis, secretion, and deacylation of Ghrelin
  • Rilapladib
  • (1R)-1,2,2-trimethylpropyl (R)-methylphosphinate
Novel PLK2 polo like kinase 2
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • CD163 mediating an anti-inflammatory response
  • NPAS4 regulates expression of target genes
  • Fostamatinib
Novel S100A8 S100 calcium binding protein A8
  • ER-Phagosome pathway
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • RHO GTPases Activate NADPH Oxidases
  • Regulation of TLR by endogenous ligand
  • Neutrophil degranulation
  • Metal sequestration by antimicrobial proteins
  • Calcium
  • Zinc
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Novel S100A9 S100 calcium binding protein A9
  • ER-Phagosome pathway
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • RHO GTPases Activate NADPH Oxidases
  • Regulation of TLR by endogenous ligand
  • Neutrophil degranulation
  • Metal sequestration by antimicrobial proteins
  • Calcium
  • Zinc
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
Novel SDC3 syndecan 3
  • Glycosaminoglycan-protein linkage region biosynthesis
  • HS-GAG biosynthesis
  • HS-GAG biosynthesis
  • HS-GAG degradation
  • Cell surface interactions at the vascular wall
  • Syndecan interactions
  • Syndecan interactions
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective B3GAT3 causes JDSSDHD
  • Defective EXT2 causes exostoses 2
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Defective B3GALT6 causes EDSP2 and SEMDJL1
  • Attachment and Entry
  • Attachment and Entry
  • Retinoid metabolism and transport
  • Respiratory syncytial virus (RSV) attachment and entry
  • RSV-host interactions
Novel SIAH1 siah E3 ubiquitin protein ligase 1
  • Netrin-1 signaling
  • Amyloid fiber formation
  • Antigen processing: Ubiquitination & Proteasome degradation
Novel SMN1 survival of motor neuron 1, telomeric
  • snRNP Assembly
  • SARS-CoV-2 modulates host translation machinery
  • Nusinersen
  • Spinal muscular atrophy (SMA), including: SMA type I (SMA1) / Werdning-Hoffman disease; SMA type II (SMA2); SMA type III (SMA3) / Kugeleberg-Welander disease; SMA type IV (SMA4); X-linked SMA 2 (SMAX2); X-linked distal SMA 3 (DSMAX); Distal SMA autosomal recessive type 4 (DSMA4); Congenital distal spinal muscular atrophy (SMAL); SMA proximal adult autosomal dominant (SMAPAD)
Novel SNCA synuclein alpha
  • Amyloid fiber formation
  • PKR-mediated signaling
  • Resveratrol
  • Dequalinium
  • Copper
  • Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
  • Parkinson's disease (PD)
Novel SOCS6 suppressor of cytokine signaling 6
  • Regulation of KIT signaling
  • Neddylation
  • Negative regulation of FLT3
Novel SOCS7 suppressor of cytokine signaling 7
Novel SPART spartin
  • Hereditary spastic paraplegia (SPG)
Novel STARD13 StAR related lipid transfer domain containing 13
  • RHOA GTPase cycle
  • RHOB GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
Novel STK11 serine/threonine kinase 11
  • AMPK inhibits chREBP transcriptional activation activity
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • Regulation of TP53 Activity through Phosphorylation
  • FOXO-mediated transcription of cell death genes
  • Peutz-Jeghers syndrome
  • Pancreatic cancer
Novel SYK spleen associated tyrosine kinase
  • GPVI-mediated activation cascade
  • GPVI-mediated activation cascade
  • FCGR activation
  • FCGR activation
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of phospholipids in phagocytosis
  • DAP12 signaling
  • Fc epsilon receptor (FCERI) signaling
  • Fc epsilon receptor (FCERI) signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Integrin signaling
  • CLEC7A (Dectin-1) signaling
  • Dectin-2 family
  • Dectin-2 family
  • Interleukin-2 signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated phagocytosis
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • Potential therapeutics for SARS
  • Inactivation of CSF3 (G-CSF) signaling
  • Inactivation of CSF3 (G-CSF) signaling
  • FLT3 signaling through SRC family kinases
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Staurosporine
  • N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
  • Tamatinib
  • 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
  • 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
  • Ellagic acid
  • Fostamatinib
  • Entospletinib
Novel SYTL4 synaptotagmin like 4
  • Platelet degranulation
Novel TAOK2 TAO kinase 2
  • Dexfosfoserine
  • Fostamatinib
Novel TIMM17A translocase of inner mitochondrial membrane 17A
  • Mitochondrial protein import
  • Mitochondrial protein import
  • Mitochondrial protein degradation
Novel TK1 thymidine kinase 1
  • G1/S-Specific Transcription
  • Pyrimidine salvage
  • Dithioerythritol
  • Thymidine 5'-triphosphate

Page 3 out of 7 pages